Market Overview:
The global PD-L1 and PIK3CA testing product market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, rising demand for personalized medicine, and technological advancements in PD-L1 and PIK3CA testing products. Based on type, the global PD-L1 and PIK3CA testing product market is segmented into PD-L1 tests and PIK3CA tests. The PD-L1 test segment is expected to grow at a higher CAGR than the PIK3CA test segment during the forecast period. This growth can be attributed to increasing demand for personalized medicine for cancer treatment. Based on application, the global PD-L1 and PIK3CA testing product market is divided into hospitals, diagnostic centers, research institutes & laboratories, pharmaceutical & biotechnology companies, CROs (contract research organizations), other end users (academic institutions), and IVD (in vitro diagnostics) manufacturers & distributors.
Product Definition:
PD-L1 and PIK3CA Testing Product is a laboratory test that helps to determine the presence or absence of PD-L1 and PIK3CA proteins in tumor tissue. The test is used to guide treatment decisions for patients with certain types of cancer.
PD-L1:
PD-L1, also known as Programmed death-1, is a protein that is found in the immune cells. It's main function is to kill infected cells. The protein plays a major role in cancer immunotherapy and tumor surveillance by the body's immune system. PD-L1 works by controlling when and how long an infected cell lives.
PIK3CA:
It is involved in the cellular response to stress and death signals. The product has been studied for its use as a biomarker for non-small cell lung cancer (NSCLC).
Application Insights:
The others application segment held the largest share of more than 50.0% in 2017. The others application category includes commercial testing laboratories and research institutes that perform immunotherapy or cancer treatment based on PD-L1 or PIK3CA tests results. These institutions are at high risk of developing resistance to cancer treatment due to frequent use of toxic drugs, which is expected to increase demand for rapid and sensitive diagnostic tests for resistant tumor cells.
Based on the type, the market has been segmented into hospital, diagnostic center, other testing sites (laboratory), and outside laboratory assisted diagnosis (OLAD).
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing healthcare expenditure are some of the factors responsible for its growth. In addition, growing awareness about cancer immunotherapy is expected to drive demand over the forecast period.
In China, around 2 million people are diagnosed with various cancers every year accounting for nearly 30% of all deaths worldwide that occur annually within China itself (excluding external causes). Moreover it has been estimated that by 2025 approximately 1 million people will die from cancer each year within China itself (excluding external causes) accounting for nearly 50% of all deaths worldwide that occur annually within China itself (excluding external causes).
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for PD-L1 and PIK3CA testing products market. According to the American Cancer Society, in 2016, around 1,685,210 new cases of cancer will be diagnosed in the U.S., and 595,690 people will die from the disease. This number is expected to rise significantly in upcoming years due to growing population and aging population.
- Rising demand for personalized medicine: The rising demand for personalized medicine is another key growth driver for PD-L1 and PIK3CA testing products market. Personalized medicine refers to treatment that is tailored specifically for a patient based on their individual genetic makeup or health condition. It offers many advantages over traditional one-size-fits-all approach to treatment, including improved efficacy and reduced side effects.
Scope Of The Report
Report Attributes
Report Details
Report Title
PD-L1 and PIK3CA Testing Product Market Research Report
By Type
PD-L1, PIK3CA
By Application
Hospital, Diagnostic Center, Others
By Companies
Agilent Technologies, Roche, QIAGEN, EntroGen, Foundation Medicine, Amoy Diagnostics, ACCB Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
157
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global PD-L1 and PIK3CA Testing Product Market Report Segments:
The global PD-L1 and PIK3CA Testing Product market is segmented on the basis of:
Types
PD-L1, PIK3CA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Diagnostic Center, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies
- Roche
- QIAGEN
- EntroGen
- Foundation Medicine
- Amoy Diagnostics
- ACCB Biotech
Highlights of The PD-L1 and PIK3CA Testing Product Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PD-L1
- PIK3CA
- By Application:
- Hospital
- Diagnostic Center
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the PD-L1 and PIK3CA Testing Product Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
PD-L1 and PIK3CA testing product is a combination of two different types of tests that can be used to determine if a person has cancer. The first test, called an immunohistochemistry assay, uses antibodies to detect the presence of PD-L1 on the surface cells of tumors. The second test, called a polymerase chain reaction (PCR) assay, uses DNA sequencing technology to identify mutations in the gene encoding PD-L1.
Some of the key players operating in the pd-l1 and pik3ca testing product market are Agilent Technologies, Roche, QIAGEN, EntroGen, Foundation Medicine, Amoy Diagnostics, ACCB Biotech.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 PD-L1 and PIK3CA Testing Product Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 PD-L1 and PIK3CA Testing Product Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 PD-L1 and PIK3CA Testing Product Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the PD-L1 and PIK3CA Testing Product Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global PD-L1 and PIK3CA Testing Product Market Size & Forecast, 2020-2028
4.5.1 PD-L1 and PIK3CA Testing Product Market Size and Y-o-Y Growth
4.5.2 PD-L1 and PIK3CA Testing Product Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 PD-L1
5.2.2 PIK3CA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Diagnostic Center
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global PD-L1 and PIK3CA Testing Product Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 PD-L1 and PIK3CA Testing Product Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 PD-L1
9.6.2 PIK3CA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Diagnostic Center
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 PD-L1
10.6.2 PIK3CA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Diagnostic Center
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 PD-L1
11.6.2 PIK3CA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Diagnostic Center
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 PD-L1
12.6.2 PIK3CA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Diagnostic Center
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 PD-L1
13.6.2 PIK3CA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Diagnostic Center
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 PD-L1 and PIK3CA Testing Product Market: Competitive Dashboard
14.2 Global PD-L1 and PIK3CA Testing Product Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Agilent Technologies
14.3.2 Roche
14.3.3 QIAGEN
14.3.4 EntroGen
14.3.5 Foundation Medicine
14.3.6 Amoy Diagnostics
14.3.7 ACCB Biotech
